{"entity":{"type":"insider","cik":"0001438226","url":"/insider/0001438226","json_url":"/insider/0001438226.json","name":"SCHULMAN AMY W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":13,"first":"2012-12-07","last":"2026-03-23","span_basis":"filed_date"},"name_variants":[{"name":"SCHULMAN AMY W","source":"filing","n_filings":13,"first_seen":"2012-12-07","last_seen":"2026-03-23"}],"transactions":[{"id":5881133,"accession":"0001438226-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001438226-26-000007","line_url":"/filing/0001438226-26-000007#line-1","is_derivative":false,"issuer_cik":"0001156039","issuer_name":"Elevance Health, Inc.","issuer_ticker":"ELV","issuer_name_source":null,"issuer_url":"/issuer/0001156039","owner_cik":"0001438226","owner_name":"SCHULMAN AMY W","owner_display_name":"SCHULMAN AMY W","owner_url":"/insider/0001438226","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26.0,"shares_display":"26","price_per_share":287.5,"price_display":"287.50","price_state":"stated","total_value":7475.0,"total_display":"7,475.00","total_whole":"7,475","shares_owned_after":218.0,"shares_owned_after_display":"218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-12","filed_date":"2026-03-23","scope":"insider"},{"id":4456090,"accession":"0001193125-25-201392","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-201392","line_url":"/filing/0001193125-25-201392","is_derivative":false,"issuer_cik":"0001295675","issuer_name":"Camp4 Therapeutics Corp","issuer_ticker":"CAMP","issuer_name_source":null,"issuer_url":"/issuer/0001295675","owner_cik":null,"owner_name":"Chee Brian; Polaris Entrepreneurs' Fund VII, L.P.; Polaris Management Co. VII, L.L.C.; Polaris Partners GP X, L.L.C.; Polaris Partners VII, L.P.; Polaris Partners X, L.P.; SCHULMAN AMY W","owner_display_name":"Chee Brian","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1307189.0,"shares_display":"1,307,189","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":1999999.17,"total_display":"1,999,999.17","total_whole":"1,999,999","shares_owned_after":2825500.0,"shares_owned_after_display":"2,825,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-11","filed_date":"2025-09-11","scope":"insider","n_lines":2},{"id":4712690,"accession":"0000950170-25-040466","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-040466","line_url":"/filing/0000950170-25-040466#line-1","is_derivative":false,"issuer_cik":"0001438226","issuer_name":"FRACTYL HEALTH, INC.","issuer_ticker":"GUTS","issuer_name_source":null,"issuer_url":"/issuer/0001438226","owner_cik":"0001438226","owner_name":"SCHULMAN AMY W","owner_display_name":"SCHULMAN AMY W","owner_url":"/insider/0001438226","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8550.0,"shares_display":"8,550","price_per_share":1.1654,"price_display":"1.17","price_state":"stated","total_value":9964.17,"total_display":"9,964.17","total_whole":"9,964","shares_owned_after":8550.0,"shares_owned_after_display":"8,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-13","filed_date":"2025-03-17","scope":"insider"},{"id":9213061,"accession":"0000950170-24-116360","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-116360","line_url":"/filing/0000950170-24-116360#line-1","is_derivative":false,"issuer_cik":"0001295675","issuer_name":"Camp4 Therapeutics Corp","issuer_ticker":"CAMP","issuer_name_source":null,"issuer_url":"/issuer/0001295675","owner_cik":null,"owner_name":"Chee Brian; Polaris Entrepreneurs' Fund VII, L.P.; Polaris Management Co. VII, L.L.C.; Polaris Partners GP X, L.L.C.; Polaris Partners VII, L.P.; Polaris Partners X, L.P.; SCHULMAN AMY W","owner_display_name":"Chee Brian","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":909090.0,"shares_display":"909,090","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":909090.0,"shares_owned_after_display":"909,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-22","scope":"insider"},{"id":2210008,"accession":"0000950170-24-114788","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-114788","line_url":"/filing/0000950170-24-114788#line-5","is_derivative":false,"issuer_cik":"0001438226","issuer_name":"Camp4 Therapeutics Corp","issuer_ticker":"CAMP","issuer_name_source":null,"issuer_url":"/issuer/0001438226","owner_cik":null,"owner_name":"Polaris Entrepreneurs' Fund VII, L.P.; Polaris Management Co. VII, L.L.C.; Polaris Partners GP X, L.L.C.; Polaris Partners VII, L.P.; Polaris Partners X, L.P.; SCHULMAN AMY W","owner_display_name":"Polaris Entrepreneurs' Fund VII, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":909090.0,"shares_display":"909,090","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":909090.0,"shares_owned_after_display":"909,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-15","scope":"insider"},{"id":2802635,"accession":"0001735276-24-000072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-24-000072","line_url":"/filing/0001735276-24-000072#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001438226","owner_name":"SCHULMAN AMY W","owner_display_name":"SCHULMAN AMY W","owner_url":"/insider/0001438226","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":240.0,"price_display":"240.00","price_state":"stated","total_value":2040000.0,"total_display":"2,040,000.00","total_whole":"2,040,000","shares_owned_after":8436.0,"shares_owned_after_display":"8,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-06-27","scope":"insider"},{"id":3272128,"accession":"0001735276-24-000058","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-24-000058","line_url":"/filing/0001735276-24-000058","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001438226","owner_name":"SCHULMAN AMY W","owner_display_name":"SCHULMAN AMY W","owner_url":"/insider/0001438226","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21700.0,"shares_display":"21,700","price_per_share":148.59659769585252,"price_display":"148.60","price_state":"stated","total_value":3224546.17,"total_display":"3,224,546.17","total_whole":"3,224,546","shares_owned_after":8499.0,"shares_owned_after_display":"8,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-29","filed_date":"2024-05-31","scope":"insider","n_lines":3},{"id":4437285,"accession":"0001209191-21-069790","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-069790","line_url":"/filing/0001209191-21-069790","is_derivative":false,"issuer_cik":"0001438226","issuer_name":"SQZ Biotechnologies Co","issuer_ticker":"SQZ","issuer_name_source":null,"issuer_url":"/issuer/0001438226","owner_cik":"0001438226","owner_name":"SCHULMAN AMY W","owner_display_name":"SCHULMAN AMY W","owner_url":"/insider/0001438226","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3700.0,"shares_display":"3,700","price_per_share":10.91,"price_display":"10.91","price_state":"stated","total_value":40367.0,"total_display":"40,367.00","total_whole":"40,367","shares_owned_after":1850.0,"shares_owned_after_display":"1,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-15","scope":"insider","n_lines":2},{"id":2785136,"accession":"0000899243-20-030318","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-030318","line_url":"/filing/0000899243-20-030318","is_derivative":false,"issuer_cik":"0001438226","issuer_name":"SQZ Biotechnologies Co","issuer_ticker":"SQZ","issuer_name_source":null,"issuer_url":"/issuer/0001438226","owner_cik":"0001438226","owner_name":"SCHULMAN AMY W","owner_display_name":"SCHULMAN AMY W","owner_url":"/insider/0001438226","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":4000000.0,"total_display":"4,000,000.00","total_whole":"4,000,000","shares_owned_after":2549306.0,"shares_owned_after_display":"2,549,306","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-03","scope":"insider","n_lines":2},{"id":8452353,"accession":"0001209191-19-024236","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-024236","line_url":"/filing/0001209191-19-024236","is_derivative":false,"issuer_cik":"0001438226","issuer_name":"Cyclerion Therapeutics, Inc.","issuer_ticker":"CYCN","issuer_name_source":null,"issuer_url":"/issuer/0001438226","owner_cik":"0001438226","owner_name":"SCHULMAN AMY W","owner_display_name":"SCHULMAN AMY W","owner_url":"/insider/0001438226","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":626117.0,"shares_display":"626,117","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10017872.0,"total_display":"10,017,872.00","total_whole":"10,017,872","shares_owned_after":604482.0,"shares_owned_after_display":"604,482","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-08","filed_date":"2019-04-10","scope":"insider","n_lines":2},{"id":5414487,"accession":"0001225208-13-012578","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001225208-13-012578","line_url":"/filing/0001225208-13-012578","is_derivative":false,"issuer_cik":"0000078003","issuer_name":"PFIZER INC","issuer_ticker":"PFE","issuer_name_source":null,"issuer_url":"/issuer/0000078003","owner_cik":"0001438226","owner_name":"SCHULMAN AMY W","owner_display_name":"SCHULMAN AMY W","owner_url":"/insider/0001438226","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":29.36269785714286,"price_display":"29.36","price_state":"stated","total_value":2055388.85,"total_display":"2,055,388.85","total_whole":"2,055,389","shares_owned_after":223497.0,"shares_owned_after_display":"223,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-15","filed_date":"2013-05-16","scope":"insider","n_lines":18},{"id":5533972,"accession":"0001209191-13-007385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-007385","line_url":"/filing/0001209191-13-007385#line-1","is_derivative":false,"issuer_cik":"0001438226","issuer_name":"Zoetis Inc.","issuer_ticker":"ZTS","issuer_name_source":null,"issuer_url":"/issuer/0001438226","owner_cik":"0001438226","owner_name":"SCHULMAN AMY W","owner_display_name":"SCHULMAN AMY W","owner_url":"/insider/0001438226","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":130000.0,"total_display":"130,000.00","total_whole":"130,000","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-06","filed_date":"2013-02-08","scope":"insider"},{"id":3401114,"accession":"0001225208-12-024844","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-12-024844","line_url":"/filing/0001225208-12-024844#line-2","is_derivative":false,"issuer_cik":"0000078003","issuer_name":"PFIZER INC","issuer_ticker":"PFE","issuer_name_source":null,"issuer_url":"/issuer/0000078003","owner_cik":"0001438226","owner_name":"SCHULMAN AMY W","owner_display_name":"SCHULMAN AMY W","owner_url":"/insider/0001438226","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":25.5593,"price_display":"25.56","price_state":"stated","total_value":2555930.0,"total_display":"2,555,930.00","total_whole":"2,555,930","shares_owned_after":246656.0,"shares_owned_after_display":"246,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-06","filed_date":"2012-12-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001156039","name":"Elevance Health, Inc.","url":"/issuer/0001156039","role":"Director","n_filings":1,"first_seen":"2026-03-23","last_seen":"2026-03-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001736730","name":"Camp4 Therapeutics Corp","url":"/issuer/0001736730","role":"Ten percent owner","n_filings":3,"first_seen":"2024-10-15","last_seen":"2025-09-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001572616","name":"FRACTYL HEALTH, INC.","url":"/issuer/0001572616","role":"Director","n_filings":1,"first_seen":"2025-03-17","last_seen":"2025-03-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Director","n_filings":2,"first_seen":"2024-05-31","last_seen":"2024-06-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001604477","name":"SQZ Biotechnologies Co","url":"/issuer/0001604477","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2020-11-03","last_seen":"2021-12-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001755237","name":"Cyclerion Therapeutics, Inc.","url":"/issuer/0001755237","role":"Director","n_filings":1,"first_seen":"2019-04-10","last_seen":"2019-04-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000078003","name":"PFIZER INC","url":"/issuer/0000078003","role":"Officer (Executive Vice President)","n_filings":2,"first_seen":"2012-12-07","last_seen":"2013-05-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001555280","name":"Zoetis Inc.","url":"/issuer/0001555280","role":"Director","n_filings":1,"first_seen":"2013-02-08","last_seen":"2013-02-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001438226","retrieved_at":"2026-08-25T12:19:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}